| 常用名 | 阿瓦斯丁 | CAS号 | 216974-75-3 |
|---|---|---|---|
| 价格 | $需询单/500mg $需询单/1g $需询单/2g $需询单/5g | 纯度 | 98.0% |
| 备货期 | 需询单 | 库存 | 现货 |
| 产品详情(用途,包装等)
Bevacizumab biosimilar is vascular endothelial growth factor directed antibody. Bevacizumab biosimilar is a recombinant humanized monoclonal IgG1 antibody that contains human framework regions and murine complementarity-determining regions. Bevacizumab biosimilar has an approximate molecular weight of 149 kDa. Bevacizumab is produced in a mammalian cell (Chinese Hamster Ovary) expression system in a nutrient medium. Bevacizumab biosimilar is supplied at a concentration of 25 mg/mL as a sterile, clear to slightly opalescent, colorless to pale brown solution, which contains 60 mg/mL α,α-trehalose dihydrate, 5.8 mg/mL sodium phosphate(monobasic, monohydrate),1.2 mg/mL sodium phosphate(dibasic, anhydrous), 0.4 mg/mL polysorbate 20, and Water for Injection. Statement: this product is used for R&D only, not for clinical usage. |